# Efficacy and Safety of Fentanyl ETHYPHARM for Breakthrough Pain in Opioid-treated Patients With Cancer

> **NCT01842893** · PHASE3 · COMPLETED · sponsor: **Ethypharm** · enrollment: 91 (actual)

## Conditions studied

- Breakthrough Pain
- Cancer

## Interventions

- **DRUG:** Fentanyl Ethypharm

## Key facts

- **NCT ID:** NCT01842893
- **Lead sponsor:** Ethypharm
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2013-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01842893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01842893, "Efficacy and Safety of Fentanyl ETHYPHARM for Breakthrough Pain in Opioid-treated Patients With Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01842893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*